154例乳腺癌化疗患者症状管理自我效能影响因素分析

Current Status of Self-efficacy for Symptom Management in 154 Breast Cancer Patients and Its Influence Factors

目的调查乳腺癌化疗患者症状管理自我效能现状,分析其影响因素。方法采用便利抽样的方法,选取2017年9月—2018年12月天津市某三级甲等肿瘤医院接受化疗的154例乳腺癌患者作为研究对象。采用一般资料调查表、症状管理自我效能量表、医院焦虑抑郁量表、乳腺癌患者生活质量量表对其进行调查。采用多元线性回归分析乳腺癌化疗患者症状管理自我效能的影响因素。结果乳腺癌化疗患者症状管理自我效能得分为(165.18±51.09)分;多元线性回归结果显示:文化程度、医疗支付方式、化疗周期和生活质量是乳腺癌化疗患者症状管理自我效能的主要影响因素(P<0.01),共解释总变异的64.7%。结论乳腺癌患者症状管理自我效能水平处于中等水平,医务人员应重点关注文化程度低、农村合作医疗、化疗周期数多及生活质量得分低的乳腺癌患者,着重为其提供管理化疗相关不良反应的健康教育及应对化疗相关不良反应的技能指导;同时也要给予针对性的护理措施,缓解化疗带来的身心不适症状,提高其症状管理自我效能水平。

Objective To investigate the current status of self-efficacy for symptom management in breast cancer patients undergoing chemotherapy and analyze its influence factors.Methods With convenient sampling method,154 breast cancer patients from one tertiary grade A hospital were investigated from September 2017 to December 2018 by using a general information questionnaire,Self-efficacy for Symptom Management Scale,Hospital Anxiety and Depression Scale and Quality of Life Questionnaire of Breast Cancer Patients.Multiple linear regression analysis was conducted for analyzing the influence factors.Results The total score of self-efficacy for symptom management scale was 165.18±51.09.Multiple regression analysis showed that education background,medical payment method,duration of chemotherapy and quality of life were main influence factors of self-efficacy for symptom management in breast cancer patients(P<0.01),which accounted for 64.7%of the total variations.Conclusion Self-efficacy for symptom management in breast cancer patients is at a medium level.More attention should go to breast cancer patients with lower education level,those with rural cooperative medical insurance,those with more chemotherapy cycles and those with lower score of quality of life.Health education on chemotherapy-related adverse reactions and skill guidance for dealing with chemotherapy-related adverse reactions and targeted care measures are beneficial to alleviating the symptoms of chemotherapy,and ultimately improving the level of self-efficacy for symptom management.